Shares of InterMune (ITMN +7.8%) moves higher today on no significant news to speak of. One...
Shares of InterMune (ITMN +7.8%) moves higher today on no significant news to speak of. One positive catalyst could be from an article posted in Seeking Alpha late Wednesday rating the stock a Buy. The gist of the article is that, despite the risk of company being dependent on a single product - Esbriet - for growth, the company has thrown all its marketing resources behind its launch and expects it to yield a high payout for the effort.
From other sites
at CNBC.com (Sep 15, 2014)
at CNBC.com (Sep 11, 2014)
at MarketWatch.com (Sep 11, 2014)
at CNBC.com (Aug 28, 2014)
at CNBC.com (Aug 26, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs